Ropinirole (as HCl) 2mg, 4mg, 6mg, 8mg, 12mg; ext-rel tabs. Swallow whole. Initially 2mg once daily for 1–2 weeks, then increase by 2mg/day at ≥1-week intervals up to max 24mg/day (for advanced ...
An early clinical trial headed by researchers at Keio University School of Medicine has shown that the Parkinson’s disease drug ropinirole is safe to use in patients with the fatal motor neuron ...
Ropinirole, a drug used for Parkinson's disease (PD), shows promise in slowing the progression of amyotrophic lateral sclerosis (ALS), early research suggests. However, at least one expert believes ...
ALS is a neurodegenerative disease with a median survival time of approximately 2 years. Muscle weakness eventually leads to respiratory failure and death. Only two drugs have been approved by the US ...
Research Triangle Park, NC (December 15, 2004) – Study results published today in the journal Movement Disorders show that Requipâ(ropinirole HCl) Tablets effectively treats the symptoms of primary ...
Philadelphia, PA (August 1, 2004) – New data published in the August issue of SLEEP shows that patients with primary Restless Legs Syndrome (RLS) and with periodic leg movements during sleep (PLMS), ...
Drug discontinued-text Requip and Requip XL are non-ergot dopamine agonists indicated for the treatment of Parkinson's disease. Requip and Requip XL are non-ergot dopamine agonists indicated for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback